ARTESUNATE Treatment of malaria 26 NR NR NR NR 3 0
AYVAKIT Treatment of gastrointestinal stromal tumors 39 72 4 10 3 40 45
BARHEMSYS Treatment of post-operative nausea and vomiting 88 79 9 1 10 14 63
BLENREP Treatment of multiple myeloma 47 78 16 2 4 53 61 
BYFAVO Sedation for short procedures 52 78 17 4 8 31 100 
CERIANNA Detection of estrogen positive lesions in breast cancer 100 15 2 83 0 NR 17 
DANYELZA Treatment of neuroblastoma 37 69 3 18 6 0 84
DETECTNET Detection of certain neuro-endocrine tumors 48 31 3 1 6 38 36
DOJOLVI Source of calories for fatty acid oxidation disorder 48 87 5 4 9 0 91
EBANGA Treatment of Ebola infection 54 NR NR NR NR 3 0
ENSPRYNG Treatment of neuromyelitis optica spectrum disorder 91 48 12 35 9 NR 29
EVRYSDI Treatment of spinal muscular atrophy 53 69 1 19 3 0 3
Ga 68 PSMA-11 Detection of specific cancer lesions in men with prostate cancer 0 85 2 4 4 72 100
GAVRETO Treatment of non-small cell lung cancer 52 50 0 41 4 37 26 
GEMTESA Treatment of symptoms of overactive bladder 85 79 15 5 73 44 90 
IMCIVREE Treatment of obesity in patients with certain rare disorder 52 67 0 4 7 0 4
INMAZEB Treatment of Ebola infection 55 NR NR NR NR NR 0
INQOVI Treatment of myelodyspastic syndromes 31 92 3 2 5 75 82 
ISTURISA Treatment of Cushing's disease 77 65 3 29 9 5 18 
KLISYRI Treatment of actinic keratosis 13 100 0 0 4 73 100 
KOSELUGO Treatment of neurofibroma 40 84 8 2 4 0 100 
LAMPIT Treatment of Chagas disease 54 71 0 0 99 0 0 
MARGENZA Treatment of metastatic HER2-positive breast cancer 99 80 5 6 9 21 33
MONJUVI Treatment of diffuse large b-cell lymphoma 46 89 0 3 NR 69 7
NEXLETOL Treatment of high LDL cholesterol 29 96 3 1 3 58 26 
NURTEC ODT Treatment of acute migraine 85 75 20 2 19 2 100 
OLINVYK Treatment of acute pain 79 72 23 2 19 18 100 
"ONGENTYS Treatment of ""off episodes"" in Parkinson's disease 42 85 0 14 NR 48 0"
ORGOVYX Treatment of prostate cancer 0 68 5 21 9 81 24 
ORLADEYO Prevention of hereditary angioedema attacks 66 94 3 1 3 8 63 
OXLUMO Treatment of primary hyperoxaluria type 1 40 80 0 11 4 0 25 
PEMAZYRE Treatment of metastatic bile duct cancer 57 71 6 15 4 31 61 
PIZENSY Treatment of chronic idiopathic constipation 76 60 31 7 38 27 100 
QINLOCK Treatment of gastrointestinal stromal tumors 43 75 8 7 1 39 47
RETEVMO Treatment of certain cancers caused by specific genes 48 69 3 22 5 34 61
RUKOBIA Treatment of HIV-1 infection 26 68 22 1 29 4 32 
SARCLISA Treatment of multiple myeloma 48 80 1 12 2 60 2 SOGROYA Replacement of growth hormone 52 67 2 29 6 14 26 
TABRECTA Treatment of non-small cell lung cancer 41 74 1 24 7 57 10 
TAUVID Detection of aggregated neurofibrillary tangles in Alzheimer's disease 50 86 5 6 5 80 77 
TAZVERIK Treatment of advanced epithelioid sarcoma 37 76 7 11 11 3 65 
TEPEZZA Treatment of thyroid eye disease 73 87 8 4 5 15 57 
TRODELVY Treatment of breast cancer 99 76 7 3 7 18 100 
TUKYSA Treatment of breast cancer 99 73 9 4 8 19 54
UPLIZNA Treatment of neuromyelitis optica spectrum disorder 94 52 9 21 19 5 18 
VEKLURY Treatment of COVID-19 37 57 18 14 21 35 65 
VILTEPSO Treatment of Duchenne muscular dystrophy 0 44 0 56 6 0 38 
VYEPTI Treatment of migraine 87 88 9 1 12 1 68 
WINLEVI Treatment of acne vulgaris 63 90 6 2 14 0 41 
XEGLYZE Treatment of head lice 84 97 1 0 66 0 100 
ZEPOSIA Treatment of multiple sclerosis 67 99 1 0 1 0 3 
ZEPZELCA Treatment of small cell lung cancer 40 75 1 1 NR 35 10 
ZOKINVY Treatment of rare conditions related to premature aging 48 NR NR NR NR 0 19